Active Immunization Against Complement Factor C5a: A New Therapeutic Approach for Alzheimer’s Disease

Journal of Neuroinflammation - United Kingdom
doi 10.1186/s12974-015-0369-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Template for New Drugs Against Alzheimer’s Disease

Cell
BiochemistryGeneticsMolecular Biology
2013English

Aβ43 in Human Alzheimer’s Disease: Effects of Active Aβ42 Immunization

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

Complement Factor C5a and C5a Receptor Contribute to Morphine Tolerance and Withdrawal-Induced Hyperalgesia in Rats

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent From Neutrophils

Journal of Immunology
AllergyImmunology
2003English

What Does Complement Do in Alzheimer’s Disease? Old Molecules With New Insights

Translational Neurodegeneration
Molecular NeuroscienceNeurologyCellularCognitive Neuroscience
2013English

Donor Immunization Against Human Leukocyte Class II Antigens Is a Risk Factor for Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Advances in Developing Novel Therapeutic Strategies for Alzheimer’s Disease

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2018English

Therapeutic Approach Targeting Apolipoprotein E Binding Region and Low-Density Lipoprotein Receptor for Alzheimer’s Disease

Neuroimmunology and Neuroinflammation
NeurologyImmunology
2018English

Correction To: Complement in the Pathogenesis of Alzheimer’s Disease

Seminars in Immunopathology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy